Group 6 Copy 82
1
Please wait...

About This Project

The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

Blast off!

Browse Other Projects on Experiment

Related Projects

Finding a Cure for Batten Disease

In March of this year, both of our daughters, Charlotte and Gwenyth, were diagnosed with Late Infantile...

A robust and clinical-friendly CRISPR diagnostic test kit for rapid SARS-COV2 detection

The high specificity and sensitivity of the CRISPR diagnostics, e.g. SHERLOCK, can detect the presence of...

Impact of Soylent Consumption on Human Microbiome Composition

As students carry out their busy lifestyles, many are turning to inexpensive and convenient drink based...

Backer Badge Funded